Robert J. Decker - Feb 25, 2025 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
VP Corporate Controller
Signature
/s/ Laura H. McFalls, as attorney-in-fact for Robert J. Decker
Stock symbol
JNJ
Transactions as of
Feb 25, 2025
Transactions value $
-$1,160,994
Form type
4
Date filed
2/26/2025, 06:42 PM
Previous filing
Feb 19, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $713K +7K +33.33% $101.87 28K Feb 25, 2025 Direct
transaction JNJ Common Stock Sale -$1.16M -7K -25% $165.88 21K Feb 25, 2025 Direct F1
holding JNJ Common Stock 620 Feb 25, 2025 By 401k F2
holding JNJ Common Stock 134 Feb 25, 2025 By ESOP F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise -$713K -7K -100% $101.87 0 Feb 25, 2025 Common Stock 7K $101.87 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $165.88 to $165.895. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2025).
F3 Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2025).
F4 Vested and exercisable on the third anniversary of the date of the grant.